Jian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian Zhang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Huaijian Hu
Xuanwu Hospital, Capital Medical University
1 shared publicationHuiliang Shen
Xuanwu Hospital, Capital Medical University
1 shared publicationLi Cao
Xuanwu Hospital, Capital Medical University
1 shared publicationMingli Feng
Department of Orthopaedics, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
1 shared publication
Latest Publications
- Open Access
- 1 November 2009
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 467 (11) , 2970-2978
Predictors of Prognosis for Elderly Patients with Poststroke Hemiplegia Experiencing Hip Fractures
Hip fracture is an important cause of mortality and disability in elderly patients, particularly in those with poststroke hemiplegia, but little information is available regarding differences of general characteristics between patients with and without hemiplegia who experience hip fractures, factors predicting recovery of prefracture ambulatory status, and mortality of patients with poststroke hemiplegia with hip fractures. We retrospectively reviewed 1379 consecutive prospectively followed patients with hip fractures treated from January 2000 to May 2006. Of the 1379 patients, 101 (7.3%) had poststroke hemiplegia. All patients were followed a minimum of 1 year if they survived more than a year or until death if they died within a year after surgery (mean, 19.5 months; range, 4–49 months). According to the American Society of Anesthesiologists (ASA) rating, the patients with hemiplegia were sicker than patients without hemiplegia, more likely to have three or more comorbidities, lower cognitive ability, weaker prefracture ambulatory status, more days of hospitalization, and higher mortality rate. Gender, ASA rating, number of comorbidities, and prefracture ambulatory status predicted mortality of hip fractures in elderly patients with poststroke hemiplegia, and the ASA rating, number of comorbidities, and cognitive ability predicted recovery of prefracture ambulatory status for these patients. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
- 1 November 2009
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 467 (11) , 2970-2978
Open AccessPredictors of Prognosis for Elderly Patients with Poststroke Hemiplegia Experiencing Hip Fractures
Hip fracture is an important cause of mortality and disability in elderly patients, particularly in those with poststroke hemiplegia, but little information is available regarding differences of general characteristics between patients with and without hemiplegia who experience hip fractures, factors predicting recovery of prefracture ambulatory status, and mortality of patients with poststroke hemiplegia with hip fractures. We retrospectively reviewed 1379 consecutive prospectively followed patients with hip fractures treated from January 2000 to May 2006. Of the 1379 patients, 101 (7.3%) had poststroke hemiplegia. All patients were followed a minimum of 1 year if they survived more than a year or until death if they died within a year after surgery (mean, 19.5 months; range, 4–49 months). According to the American Society of Anesthesiologists (ASA) rating, the patients with hemiplegia were sicker than patients without hemiplegia, more likely to have three or more comorbidities, lower cognitive ability, weaker prefracture ambulatory status, more days of hospitalization, and higher mortality rate. Gender, ASA rating, number of comorbidities, and prefracture ambulatory status predicted mortality of hip fractures in elderly patients with poststroke hemiplegia, and the ASA rating, number of comorbidities, and cognitive ability predicted recovery of prefracture ambulatory status for these patients. Level of Evidence: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.